ACSM Publishes New Expert Consensus Statements on Compendium of Task Forces for Clinical Considerations for Competitive Sports Participation for Competitive Athletes with Cardiovascular Abnormalities
In November, ACSM published a new series of pronouncements titled “Compendium of Task Forces for Clinical Considerations for Competitive Sports Participation for Competitive Athletes with Cardiovascular Abnormalities” in the Medicine & Science in Sports & Exercise (MSSE) journal.
These official ACSM statements, explain the evidence behind the 2025 scientific statement from the American Heart Association (AHA) and American College of Cardiology (ACC), which moved the field away from automatic medical disqualifications and toward athlete-centered shared decision-making. These publications provide the detailed rationale for the updated clinical considerations for sports participation for competitive athletes with cardiovascular abnormalities. The information included details the background for topics/diseases/conditions across the landscape of general cardiology, evidence supportive of changes in the updated guidelines, and critical future directions as we look to updated guidance in future years.
There are significant updates across all topics in sports and general cardiology and considerations for competitive sports. Significant changes include classification of sports, consideration for athletes on anti-coagulation, pre-participation evaluations and screening ECG, genetic cardiomyopathies, valvular heart disease, myocarditis, congenital heart disease, aortic conditions, arrhythmias, cardiac channelopathies, athletes with pulmonary embolus, Masters athletes with cardiac conditions, and pregnant competitive athletes.
Each publication is matched to a section of the 2025 statement that includes:
Updates to considerations have shifted away from a paternalistic and conservative practice of automatic medical disqualifications without including the voice of the athlete to practices grounded in shared decision-making that are very much athlete centered.
In addition, data over the last 10 years have shown that cardiac risks for many cardiac conditions are not as high risk as previously believed. The combination of these two principals has led to changes in clinical guidance that are provided in the 2025 AHA/ACC Scientific Statement and summarized in these Task Force documents along with detailed discussions of the rationale that led to updates.
The administration of these statements were chaired by Jonathan H. Kim, M.D., M.Sc., Benjamin D. Levine, MD, FACSM and Aaron L. Baggish, MD, FASCM, with the 12 statements written by 46 additional authors in sports cardiology, sports medicine, exercise physiology and cardiovascular disease from nine countries contributed to the series.
The statements are freely available to view and download. Access to the statements can be found here: ACSM Official Statements
Also linked is the 2025 AHA/ACC scientific statement published in Circulation and the Journal of the American College of Cardiology
As an ACSM official pronouncement, the statements were reviewed and approved by the ACSM Pronouncements Committee and ACSM Administrative Council and Board of Trustees. ACSM Expert Consensus statements serve as official statements (pronouncements) of the College on topics of high importance or with broad impact in the areas of sports medicine and exercise science.
More information on ACSM’s pronouncements and ACSM’s additional official statements can be found here: ACSM Pronouncements and Scientific Communications